(Q39945195)

English

Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

9

0 references

object named as

Lucia Nobili

2

0 references

Jessika Bertacchini

object named as

Jessika Bertacchini

7

0 references

object named as

Antonino Neri

11

0 references

author name string

Donata Verdelli

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Daniela Intini

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Maria Cosenza

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Monica Civallero

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Giorgio Lambertenghi Deliliers

8

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Luigia Lombardi

10

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

publication date

1 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Hematological Oncology

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

23-30

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun.

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

21 January 2018

The AKT kinase is activated in multiple myeloma tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl).

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations.

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination.

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

IRF4 addiction in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

An APRIL to remember: novel TNF ligands as therapeutic targets

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody targeting of B-cell maturation antigen on malignant plasma cells

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FHON.875

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HON.875

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39945195&oldid=1879249225"